Rachel K. King is of NOVAVAX INC. Currently has a direct ownership of 18,920 shares of NVAX, which is worth approximately $164,604. The most recent transaction as insider was on Jun 12, 2024, when has been sold 6,670 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.9K
0% 3M change
88.26% 12M change
Total Value Held $164,604

Rachel K. King Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
BUY
Exercise of conversion of derivative security
-
6,670 Added 26.06%
18,920 Common Stock
Jun 10 2023
BUY
Exercise of conversion of derivative security
-
3,100 Added 23.57%
10,050 Common Stock
Jun 17 2022
BUY
Exercise of conversion of derivative security
-
700 Added 9.15%
6,950 Common Stock
Jun 25 2021
BUY
Exercise of conversion of derivative security
-
6,900 Added 41.57%
9,700 Common Stock
May 19 2021
BUY
Open market or private purchase
$97,748 $139.64 p/Share
700 Added 20.0%
2,800 Common Stock

Also insider at

GLYC
GLYCOMIMETICS INC Healthcare
FULC
Fulcrum Therapeutics, Inc. Healthcare
RKK

Rachel K. King

Gaithersburg, MD

Track Institutional and Insider Activities on NVAX

Follow NOVAVAX INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVAX shares.

Notify only if

Insider Trading

Get notified when an Novavax Inc insider buys or sells NVAX shares.

Notify only if

News

Receive news related to NOVAVAX INC

Track Activities on NVAX